2118356-95-7
Chemical Structure
CDK9 ligand-Linker Conjugate 1
- CAS. Nr.: 2118356-95-7
- Formula:C20H26BrN3O2
- Molecular Weight:420.34
IUPAC Name: 2-(4-((5-bromopentyl)oxy)phenyl)-N-(5-cyclobutyl-1H-pyrazol-3-yl)acetamide
InChIKey: FDZFKKNNFNQIHQ-UHFFFAOYSA-N
SMILES: O=C(CC1=CC=C(OCCCCCBr)C=C1)NC2=CC(C3CCC3)=NN2
Biological Activity: CDK9 ligand-Linker Conjugate 1 is a compound formed by conjugation of a selective CDK9 ligand and a PROTAC linker. CDK9 ligand-Linker Conjugate 1 can be further coupled with an E3 ubiquitin ligase ligand to synthesize CDK9 PROTAC (HY-103628). CDK9 ligand-Linker Conjugate 1 is applicable to the research of CDK9-related disease states[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK9 ligand-Linker Conjugate 1 | CDK9 ligand-Linker Conjugate 1 is a compound formed by conjugation of a selective CDK9 ligand and a PROTAC linker. CDK9 ligand-Linker Conjugate 1 can be further coupled with an E3 ubiquitin ligase ligand to synthesize CDK9 PROTAC (HY-103628). CDK9 ligand-Linker Conjugate 1 is applicable to the research of CDK9-related disease states. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
